Publications by authors named "B Guruprasad"

Claim this Profile
I
Impact of Baseline Vision on Outcomes in Diabetic Macular Edema in VISTA/VIVID.
Michael A Singer, Dilraj S Grewal, Preston O'Brien, Fabiana Silva, Weiming Du, Guruprasad B

Ophthalmol Retina· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials.
Michael Singer, Arshad M Khanani, Armin Wolf, Rita Flores, Jay Chhablani, Guruprasad B

Ophthalmologica· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antivascular endothelial growth factor agents for wet age-related macular degeneration: an IRIS registry analysis.
Mathew W MacCumber, Justin S Yu, Alexandros Sagkriotis, Guruprasad B, Bhavya Burugapalli

Can J Ophthalmol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies.
David Eichenbaum, David M Brown, Michael Ip, Arshad M Khanani, Marta S Figueroa, Guruprasad B

Retina· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy Outcomes of Brolucizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration Patients with Early Residual Fluid.
Rishi P Singh, Chirag Jhaveri, Charles C Wykoff, Richard P Gale, Giovanni Staurenghi, Guruprasad B

Ophthalmol Retina· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis